Induced Impairment of Neurogenesis and Brain Diseases

The impairment of neurogenesis may be induced after pre- and post-natal chemical and biological toxin, alcohol, or radiation exposure, drug treatment, hormone imbalances, stress, pain, hypoxia, brain trauma, malnutrition, and aging. It also occurs as a result of genetic disorders such as Down syndro...

Full description

Saved in:
Bibliographic Details
Other Authors: Tang, FengRu (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_96672
005 20230202
003 oapen
006 m o d
007 cr|mn|---annan
008 20230202s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-6213-1 
020 |a 9783036562148 
020 |a 9783036562131 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-6213-1  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a PSAN  |2 bicssc 
100 1 |a Tang, FengRu  |4 edt 
700 1 |a Tang, FengRu  |4 oth 
245 1 0 |a Induced Impairment of Neurogenesis and Brain Diseases 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (282 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The impairment of neurogenesis may be induced after pre- and post-natal chemical and biological toxin, alcohol, or radiation exposure, drug treatment, hormone imbalances, stress, pain, hypoxia, brain trauma, malnutrition, and aging. It also occurs as a result of genetic disorders such as Down syndrome (DS), autism, fragile X syndrome (FXS), neurological disorders including Alzheimer's disease (AD), Parkinson's disease (PD) epilepsy, and Huntington's disease (HD), and neuropsychiatric disorders such as depression and schizophrenia; however, the causal relationship between the impairment of neurogenesis and neurological and neuropsychiatric disorders remains unknown. In this Special Issue, entitled "Induced Impairment of Neurogenesis and Brain Diseases", original animal or cell experimental research and review papers were combined to discuss different causes of the impairment of neurogenesis, relevant neurobehavioral changes, molecular mechanisms, and therapeutic approaches. The aim is to update researchers and clinicians about the complexity of the development of the impairment of neurogenesis, the importance of the involvement of the impairment of neurogenesis in neurological and neuropsychiatric disorders, and to provide some clues for designing novel therapeutic approaches by targeting the impairment of neurogenesis to effectively prevent or treat different genetic, neurological, and neuropsychological disorders. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Neurosciences  |2 bicssc 
653 |a neurogenesis 
653 |a TGF-β 
653 |a smad 
653 |a depression 
653 |a stress 
653 |a complementary and alternative medicines 
653 |a natural products 
653 |a peripheral nerve injury 
653 |a nerve repair 
653 |a nerve regeneration 
653 |a functional recovery 
653 |a neuroinflammation 
653 |a microglia 
653 |a TSPO 
653 |a mitochondria 
653 |a cytokines 
653 |a antioxidants 
653 |a γ-irradiation 
653 |a miR-34a-5p 
653 |a tia1 
653 |a N6-methyladenosine 
653 |a Mettl3 
653 |a Mettl14 
653 |a Fto 
653 |a Ythdf1 
653 |a neurodevelopment 
653 |a neurodegeneration 
653 |a SMG6 
653 |a NMD 
653 |a neurodevelopmental syndromes 
653 |a ionizing radiation 
653 |a aging 
653 |a brain 
653 |a oxidative stress 
653 |a mitochondrial dysfunction 
653 |a DNA damage 
653 |a gut microbiota 
653 |a gut-brain axis 
653 |a adult neurogenesis 
653 |a ageing 
653 |a neural stem cells 
653 |a nutrients 
653 |a polyphenols 
653 |a TRIM32 
653 |a excitatory-inhibitory imbalance 
653 |a cortex development 
653 |a ASD 
653 |a NPCs 
653 |a GHSR1 
653 |a ghrelin 
653 |a hypoxia 
653 |a transcription factors 
653 |a progenitor cells 
653 |a adult hippocampal neurogenesis 
653 |a Alzheimer's disease 
653 |a Aβ peptide 
653 |a DNA methylation 
653 |a gene expression 
653 |a NXN 
653 |a CNTNAP1 
653 |a SEPT5-GP1BB 
653 |a TBX5 
653 |a miR-146b 
653 |a cognition 
653 |a anxiety 
653 |a astrocytes 
653 |a neuronal development 
653 |a Gdnf 
653 |a microcephaly 
653 |a MCPH1 
653 |a central domain 
653 |a brain development 
653 |a gonad development 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/6617  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/96672  |7 0  |z DOAB: description of the publication